BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghebre Y, Raghu G. Proton pump inhibitors in IPF: beyond mere suppression of gastric acidity. QJM. 2016;109:577-579. [PMID: 27647940 DOI: 10.1093/qjmed/hcw115] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Yang M, Dong J, An J, Liu L, Chen L. Effect of anti-reflux therapy on pulmonary function in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. J Thorac Dis 2021;13:5776-87. [PMID: 34795926 DOI: 10.21037/jtd-21-771] [Reference Citation Analysis]
2 Martinez FJ, Collard HR, Pardo A, Raghu G, Richeldi L, Selman M, Swigris JJ, Taniguchi H, Wells AU. Idiopathic pulmonary fibrosis. Nat Rev Dis Primers 2017;3:17074. [PMID: 29052582 DOI: 10.1038/nrdp.2017.74] [Cited by in Crossref: 295] [Cited by in F6Publishing: 276] [Article Influence: 59.0] [Reference Citation Analysis]
3 Targownik LE, Fisher DA, Saini SD. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review. Gastroenterology 2022:S0016-5085(21)04083-X. [PMID: 35183361 DOI: 10.1053/j.gastro.2021.12.247] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
4 Allaix ME, Rebecchi F, Morino M, Schlottmann F, Patti MG. Gastroesophageal Reflux and Idiopathic Pulmonary Fibrosis. World J Surg 2017;41:1691-7. [PMID: 28258461 DOI: 10.1007/s00268-017-3956-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Taneja G, Sharma AK, Khanna D, Rajput SK. Effect of pantoprazole on I-R-induced myocardial injury in diabetic rats targeting inflammatory cytokine release and oxidative stress. Iran J Basic Med Sci 2021;24:615-22. [PMID: 34249262 DOI: 10.22038/ijbms.2021.51624.11714] [Reference Citation Analysis]
6 Kreuter M, Spagnolo P, Wuyts W, Renzoni E, Koschel D, Bonella F, Maher TM, Kolb M, Weycker D, Kirchgässler KU, Costabel U. Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone. Respiration 2017;93:415-23. [PMID: 28399537 DOI: 10.1159/000468546] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 6.6] [Reference Citation Analysis]
7 Zippi M, Fiorino S, Budriesi R, Micucci M, Corazza I, Pica R, de Biase D, Gallo CG, Hong W. Paradoxical relationship between proton pump inhibitors and COVID-19: A systematic review and meta-analysis. World J Clin Cases 2021; 9(12): 2763-2777 [PMID: 33969059 DOI: 10.12998/wjcc.v9.i12.2763] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Chaudhuri N, George PM, Kreuter M, Molina-Molina M, Rivera-Ortega P, Stella GM, Stewart I, Spencer LG, Wells AU, Jenkins RG. Reply to Althuwaybi et al.: Hospitalization Outcomes for COVID-19 in Patients with Interstitial Lung Disease: A Potential Role for Aerodigestive Pathophysiology? Am J Respir Crit Care Med 2021;203:522-4. [PMID: 33217244 DOI: 10.1164/rccm.202011-4146LE] [Reference Citation Analysis]
9 Fidler LM, Johannson KA. Antacid Therapy in Idiopathic Pulmonary Fibrosis: A Swinging Pendulum. Chest 2021;159:475-6. [PMID: 33563432 DOI: 10.1016/j.chest.2020.09.239] [Reference Citation Analysis]
10 Nelson C, Lee J, Ko K, Sikora AG, Bonnen MD, Enkhbaatar P, Ghebre YT. Therapeutic Efficacy of Esomeprazole in Cotton Smoke-Induced Lung Injury Model. Front Pharmacol 2017;8:16. [PMID: 28184197 DOI: 10.3389/fphar.2017.00016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
11 Taneja G, Thanikachalam PV, Rajput SK. Dose and time-dependent toxicological impact of pantoprazole on vascular endothelium and renal tissue. Toxicol Lett 2020;333:97-104. [PMID: 32763312 DOI: 10.1016/j.toxlet.2020.07.031] [Reference Citation Analysis]
12 Ghebre YT, Raghu G. Response to letter regarding article, 'proton pump inhibitors in IPF: beyond mere suppression of gastric acidity'. QJM 2017;110:263-4. [PMID: 28158726 DOI: 10.1093/qjmed/hcx022] [Reference Citation Analysis]
13 Ghebre YT. Proton Pump Inhibitors in IPF: A Call for Clinical Trials. Front Pharmacol 2018;9:499. [PMID: 29867501 DOI: 10.3389/fphar.2018.00499] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]